In patients with IPF, Mishra et al. showed that doxycycline therapy reduced the levels of MMP-9, MMP-3, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor in bronchial alveolar lavage fluid to near control values [16]. The gene discussed is MMP3; the disease is idiopathic pulmonary fibrosis.